Menu
Search
|

Menu

Close
X

Amedica Corp AMDA.OQ (NASDAQ Stock Exchange Capital Market)

2.27 USD
+0.05 (+2.25%)
As of 3:59 PM EST
chart
Previous Close 2.22
Open 2.27
Volume 5,635
3m Avg Volume 13,714
Today’s High 2.33
Today’s Low 2.27
52 Week High 6.92
52 Week Low 2.21
Shares Outstanding (mil) 3.02
Market Capitalization (mil) 6.71
Forward P/E --
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
3.00 Mean rating from 2 analysts

KEY STATS

Revenue (mm, USD)
FY17
9
FY16
15
FY15
19
EPS (USD)
FY17
-1.429
FY16
-14.863
FY15
-86.236
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
--
35.76
Price to Sales (TTM)
vs sector
0.54
8.59
Price to Book (MRQ)
vs sector
0.64
5.23
Price to Cash Flow (TTM)
vs sector
--
26.13
Total Debt to Equity (MRQ)
vs sector
44.20
15.32
LT Debt to Equity (MRQ)
vs sector
0.00
11.95
Return on Investment (TTM)
vs sector
-45.00
13.59
Return on Equity (TTM)
vs sector
-49.41
15.20

EXECUTIVE LEADERSHIP

B. Sonny Bal
Chairman of the Board, President, Chief Executive Officer, Chief Financial Officer, Since 2016
Salary: $79,423.00
Bonus: --
Bryan McEntire
Chief Technology Officer, Since 2012
Salary: $217,995.00
Bonus: $5,000.00
Dana Lyons
Vice President - Sales and Marketing, Since 2016
Salary: --
Bonus: --
Eric Stookey
Independent Director, Since 2014
Salary: --
Bonus: --
David Truetzel
Independent Director, Since
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Medical Equipment, Supplies & Distribution
Address:

1885 West 2100 Street
SALT LAKE CITY   UT   84119

Phone: +1801.8393516

Amedica Corporation is a commercial biomaterial company. The Company is a vertically integrated silicon nitride orthopedic medical device manufacturer. It is focused on using its silicon nitride ceramic technology platform to develop, manufacture and sell a range of medical devices. It is also engaged in developing wear- and corrosion-resistant implant components for hip and knee arthroplasty. The Company markets its Valeo family of silicon nitride interbody spinal fusion devices in the United States, Europe and Brazil for use in the cervical and thoracolumbar areas of the spine. In addition to its silicon nitride-based spinal fusion products, it markets a line of non-silicon nitride spinal surgery products, which allows the Company to provide surgeons and hospitals with a solution for spinal procedures. Its Valeo interbody spinal fusion devices include Anterior Lumbar, Posterior Lumbar, Oblique Lumbar, Transforaminal Lumbar, Lateral Lumbar, Cervical and Corpectomy.

SPONSORED STORIES